Here are the biggest analyst calls of the day: Biogen, Apple, Micron, & more

France Nouvelles Nouvelles

Here are the biggest analyst calls of the day: Biogen, Apple, Micron, & more
France Dernières Nouvelles,France Actualités
  • 📰 CNBC
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 72%

Here are the biggest calls on Wall Street on Thursday

William Blair downgraded Biogen because the Aducanumab trials were being discontinued due to an interim futility analysis determining the trials were unlikely to meet the primary endpoints.

Citi is staying positive on Apple and expects the company to raise its dividend and increase its buyback authorization. Goldman Sachs upgraded Qorvo due to its smartphone stabilization, growing 5G infrastructure business, and margin expansion at a compelling valuation. Goldman Sachs sees significant upside potential to the stock and says Arista is one of the highest EPS growth profiles in its coverage.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

CNBC /  🏆 12. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Stocks making the biggest moves premarket: Biogen, Boeing, Walmart, Apple, Clorox & moreStocks making the biggest moves premarket: Biogen, Boeing, Walmart, Apple, Clorox & moreSome of the names on the move ahead of the open.
Lire la suite »

Biogen is crashing after scrapping its late-stage Alzheimer's drug trialsBiogen is crashing after scrapping its late-stage Alzheimer's drug trialsBiogen shares crashed more than 25% in pre-market trading after discontinuing two late-stage Alzheimer's drug trials with Eisai.
Lire la suite »

Biogen shares plunge more than 25% after ending trial for Alzheimer's drug AducanumabBiogen shares plunge more than 25% after ending trial for Alzheimer's drug Aducanumab
Lire la suite »

Biogen's stock plummets after phase 3 trial of Alzheimer's treatment discontinuedBiogen's stock plummets after phase 3 trial of Alzheimer's treatment discontinuedShares of Biogen Inc. plummeted 26% toward a near 3-year low in premarket trade Thursday, after the biotechnology company and Japan's Eisai Co. Ltd. said...
Lire la suite »

Stocks making the biggest moves premarket: Biogen, Boeing, Walmart, Apple, Clorox & moreStocks making the biggest moves premarket: Biogen, Boeing, Walmart, Apple, Clorox & moreSome of the names on the move ahead of the open.
Lire la suite »

Here are the biggest analyst calls of the day: Lyft, Monster, FedEx, Rockwell Automation & moreHere are the biggest analyst calls of the day: Lyft, Monster, FedEx, Rockwell Automation & moreHere are the biggest calls on Wall Street on Wednesday
Lire la suite »

Here are the biggest analyst calls of the day: Facebook, Dollar General, Chipotle & moreHere are the biggest analyst calls of the day: Facebook, Dollar General, Chipotle & moreHere are the biggest calls on Wall Street on Monday:
Lire la suite »

Here are the biggest analyst calls of the day: Domino's, Yum Brands, Booking Holdings, BoeingHere are the biggest analyst calls of the day: Domino's, Yum Brands, Booking Holdings, BoeingHere are the biggest calls on Wall Street on Tuesday
Lire la suite »

Here are the biggest analyst calls of the day: Amazon, Netflix, AT&T, Oracle, Zillow & moreHere are the biggest analyst calls of the day: Amazon, Netflix, AT&T, Oracle, Zillow & moreHere are the biggest calls on Wall Street on Friday:
Lire la suite »



Render Time: 2025-03-11 20:04:17